<unk>  (FLC) is a rare subtype of primary liver cancer.<unk>  was first described Edmondson in 1956.<unk>  is most commonly seen in children and young adults. The pathogenesis of<unk>  is characterized by the lack of cirrhosis.  Common causes of<unk> , include: active hepatic inflammation, hepatitis B or C viral infection, alcohol-related liver disease, nonalcoholic fatty liver disease, and dietary aflatoxin B1. The majority of patients with<unk>  remain asymptomatic for years. Early clinical features include abdominal pain, weight loss, and malaise.  If left untreated, the majority of patients with<unk>   may progress to develop metastasis to abdominal lymph nodes, peritoneum, and lung. Common complications of<unk>  include: hepatic failure, caval compression syndrome, gynecomastia, and cold agglutinin disease. Surgical resection or transplantation is the standard of care for<unk><unk>  (FLC) for eligible patients. Trans-arterial chemo-embolization (TACE) may be a useful option in patients who have unresectable disease.
Fibrolamellar hepatocellular carcinoma
Xanthomatous biliary cirrhosis
Hepatocellular adenoma
Focal fatty liver
Hepatocellular adenoma pathophysiology
Hepatocellular carcinoma
Hepatocellular carcinoma stagin
Lupoid hepatitis